Loading...
Loading...
APEN| Name | Value |
|---|---|
| Revenues | 19.6M |
| Cost of Revenue | 8.8M |
| Gross Profit | 10.7M |
| Operating Expense | 17.0M |
| Operating I/L | -6.3M |
| Other Income/Expense | -5.0M |
| Interest Income | 0.0M |
| Pretax | -11.3M |
| Income Tax Expense | 0.2M |
| Net Income/Loss | -11.4M |
Apollo Endosurgery, Inc. specializes in the design, development, and commercialization of medical devices. Their flagship products include the OverStitch and OverStitch Sx Endoscopic Suturing Systems, which enable advanced endoscopic procedures, and the Orbera intragastric balloon system that reduces stomach capacity. They also offer the X-Tack Endoscopic HeliX Tacking System for gastrointestinal tract defects. The company generates revenue by selling these products to medical service providers, hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries.
